General Statement of Disclosure:
CONSULTING FEES/HONORARIA: RCE Technologies(SIGNIFICANT), HeartSciences(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: RCE Technologies(SIGNIFICANT)
CONSULTING FEES/HONORARIA: RCE Technologies(SIGNIFICANT), HeartSciences(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: RCE Technologies(SIGNIFICANT)
© 2024 American College of Cardiology Foundation. All rights reserved.